Noveome
is a Pennsylvania-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of inflammatory and neurological disorders... Read moreNoveome
is a Pennsylvania-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of inflammatory and neurological disorders... Read more
News
Nov 20, 2024
EIN Presswire
Press Release: Noveome : Noveome Biotherapeutics Announces Issuance of U.S. Patent No. 12,121,546 "Treatment of Systemic Inflammatory Responses"
Nov 14, 2024
EIN Presswire
Press Release: Noveome : Noveome Biotherapeutics Completes Dosing of First Baby in Clinical Trial for Treatment of Necrotizing Enterocolitis
Dec 11, 2023
EIN Presswire
Press Release: Noveome : Noveome Biotherapeutics, Inc. Receives FDA Notification to Proceed with its Phase 1-2 Clinical Trial in Treatment of NEC
Aug 21, 2023
Technically Media
Noveome: Pittsburgh's Noveome Biotherapeutics closed $20.7M of a Series E
Aug 18, 2023
The Business Journals
Noveome: Noveome closes on $20.7M, halfway to $40M goal
Aug 02, 2023
sec
Noveome: Noveome Received $20.7M in Series E Funding
May 25, 2022
The Business Journals
Noveome: Noveome Biotherapeutics earns FDA designations for new biologic application
May 24, 2022
FirstWord Pharma
Noveome: Noveome Biotherapeutics Receives Rare Pediatric Disease Designation and Orphan Drug Designation for the Treatment of Necrotizing Enterocolitis in Neonates
Jul 19, 2021
The Business Journals: Pittsburgh Business Times
Noveome: New Noveome Biotherapeutics CEO sees big potential in Pittsburgh
Jun 23, 2021
Markets Insider
Noveome: Noveome Biotherapeutics, Inc. Commences Phase 1 Clinical Study of ST266 Application for Infectious Disease (including COVID-19)
Noveome Competitors
1
2
3
4
5
6
7
8
9
10